Cardiovascular system

Branched Stent Grafts Market Size To Reach $477.5 Million By 2028: Grand View Research, Inc.

Retrieved on:

Wednesday, July 28, 2021

Medical specialties, Angiology, Cardiovascular system, Vascular diseases, Vascular surgery, Interventional radiology, Thoracic aortic aneurysm, Aneurysm, Aortic aneurysm, Stent, Gustavo S. Oderich, Endovascular aneurysm repair

SAN FRANCISCO, July 28, 2021 /PRNewswire/ -- The global branched stent grafts market size is anticipated to reach USD 477.53 million by 2028, registering a CAGR of 7.9% from 2021 to 2028, according to a new report by Grand View Research, Inc.

Key Points:

SAN FRANCISCO, July 28, 2021 /PRNewswire/ -- The global branched stent grafts market size is anticipated to reach USD 477.53 million by 2028, registering a CAGR of 7.9% from 2021 to 2028, according to a new report by Grand View Research, Inc.
In addition, the preference for endovascular treatment for aortic aneurysms further boosts the market growth.
Thoracic aortic aneurysm and AAA are types of aortic aneurysms; aneurysms can also occur in other parts of the body.
Grand View Research has segmented the global branched stent grafts market on the basis of type, application, and region:
Branched Stent Grafts Type Outlook (Volume, Units; Revenue, USD Million, 2021 - 2028)
Branched Stent Grafts Application Outlook (Volume, Units; Revenue, USD Million, 2021 - 2028)

Branched Stent Grafts Market Size To Reach $477.5 Million By 2028: Grand View Research, Inc.

Retrieved on:

Wednesday, July 28, 2021

SAN FRANCISCO, July 28, 2021 /PRNewswire/ -- The global branched stent grafts market size is anticipated to reach USD 477.53 million by 2028, registering a CAGR of 7.9% from 2021 to 2028, according to a new report by Grand View Research, Inc.

Key Points:

SAN FRANCISCO, July 28, 2021 /PRNewswire/ -- The global branched stent grafts market size is anticipated to reach USD 477.53 million by 2028, registering a CAGR of 7.9% from 2021 to 2028, according to a new report by Grand View Research, Inc.
In addition, the preference for endovascular treatment for aortic aneurysms further boosts the market growth.
Thoracic aortic aneurysm and AAA are types of aortic aneurysms; aneurysms can also occur in other parts of the body.
Grand View Research has segmented the global branched stent grafts market on the basis of type, application, and region:
Branched Stent Grafts Type Outlook (Volume, Units; Revenue, USD Million, 2021 - 2028)
Branched Stent Grafts Application Outlook (Volume, Units; Revenue, USD Million, 2021 - 2028)

Semler to Report Second Quarter and First Half 2021 Financial Results and Host Conference Call on August 2, 2021

Retrieved on:

Wednesday, July 21, 2021

Cardiovascular system, Circulatory system, Cardiovascular physiology, Angiology, Artery, Peripheral artery disease, Conference call

We encourage participants to pre-register for the conference call using the following link: https://dpregister.com/sreg/10158825/eb5d672fd4 .

Key Points:

We encourage participants to pre-register for the conference call using the following link: https://dpregister.com/sreg/10158825/eb5d672fd4 .
Callers who pre-register will be given a conference passcode and unique PIN to gain immediate access to the call and bypass the live operator.
Participants may pre-register at any time, including up to and after the call start time.
QuantaFlois a rapid point-of-care test that measures arterial blood flow in the extremities to aid in the diagnosis of peripheral arterial disease.

OneProjects, VistaMed and Tyndall Institute Awarded Funding to Improve Treatment of Cardiac Arrhythmias

Retrieved on:

Wednesday, July 14, 2021

Atrial fibrillation or AFib is an irregular heartbeat or cardiac arrhythmia which can lead to blood clots, stroke, and heart failure.

Key Points:

Atrial fibrillation or AFib is an irregular heartbeat or cardiac arrhythmia which can lead to blood clots, stroke, and heart failure.
First procedure success rates for patients with atrial fibrillation undergoing cardiac ablation can be as low as 50% and OneProjects aims to increase this significantly.
A consortium of three partners were awarded the grant, led by the medical device company, OneProjects with the Tyndall National Institute and VistaMed / Freudenberg Medical .
The resulting platform technology will achieve better patient outcomes treating millions of people worldwide who suffer with cardiac arrhythmias, said Patrick Mulholland, Managing Director at VistaMed.

Global StopAfib.org Virtual Atrial Fibrillation Patient Conference, August 6-8

Retrieved on:

Tuesday, July 13, 2021

Cardiac arrhythmia, Branches of biology, Atrial fibrillation, Circulatory system, Cardiovascular system, Fibrillation, Arrhythmia, Stroke, Familial atrial fibrillation, XEN-D0101

Virtual Atrial Fibrillation Patient Conference is for those living with atrial fibrillation (afib), the most common irregular heartbeat, which increases stroke risk by 500%.

Key Points:

Virtual Atrial Fibrillation Patient Conference is for those living with atrial fibrillation (afib), the most common irregular heartbeat, which increases stroke risk by 500%.
Atrial Fibrillation Patient Conference.
"Our annual patient conference is a labor of love and a gift," said Mellanie True Hills, founder of StopAfib.org.
Virtual Atrial Fibrillation Patient Conference is open.

Ischemia Care Announces Industry and Hospital Program to Support Molecular Diagnostic Testing in Ischemic Stroke

Retrieved on:

Thursday, July 8, 2021

Ischemia Care today announced a new program called CLASSICS, which stands for Clinical Laboratory and Strategic Support to Identify Stroke and Cause of Stroke to commercialize a portfolio of hospital-based blood tests across industry leading laboratory platforms for ischemic stroke and underlying causes (such as atrial fibrillation) used in the hospital setting.

Key Points:

Ischemia Care today announced a new program called CLASSICS, which stands for Clinical Laboratory and Strategic Support to Identify Stroke and Cause of Stroke to commercialize a portfolio of hospital-based blood tests across industry leading laboratory platforms for ischemic stroke and underlying causes (such as atrial fibrillation) used in the hospital setting.
Ischemia Care is pioneering the field of molecular testing in stroke and related cardiovascular disease, recently completing enrollment in a 1,700-patient clinical trial at 20 major hospital systems titled, Biomarkers of Acute Stroke Etiology (BASE NCT02014896) and commenced a follow on in-market trial called Biomarkers of Acute Stroke in Clinic (BASIC NCT03897478).
Ischemia Care has accumulated over 5,000 patient blood samples and clinical data representing a 10-test pipeline.
The challenge is realizing the full value of this existing data, so Ischemia Care is creating an innovative program.

Scan an Entire Heart in 1-2 Heartbeats - Modern Heart and Vascular Institute

Retrieved on:

Monday, July 5, 2021

Circulatory system, Cardiovascular system, Medical specialties, Heart diseases, Aging-associated diseases, Peripheral artery disease, Coronary artery disease, Heart failure, Artery, Heart, Interventional radiology, Cardiovascular disease in Australia

The providers at Modern Heart and Vascularperformthese extensive diagnostic tests in an outpatient setting to avoid the need for invasive testing.

Key Points:

The providers at Modern Heart and Vascularperformthese extensive diagnostic tests in an outpatient setting to avoid the need for invasive testing.
To learn more about cardiac computed tomography (CT) at Modern Heart and Vascular Institute, please click here .
Modern Heart and Vascular Institute assists with variousheart & vascular symptoms & issues such as chest pain, high cholesterol, congestive heart failure, peripheral arterial disease (PAD), arrhythmia, coronary artery disease, high blood pressure and much more.Modern Heart and Vascular specializes in all aspects of cardiovascular and metabolic diseases.
For comprehensive cardiovascular care, contact Modern Heart and Vascular Institute by phone or online today.

Endovascular Aneurysm Repair (EVAR) Market Report 2021: Global Industry Trends, Share, Size, Growth, Opportunity and Forecasts, 2015-2020 & 2021-2026 - ResearchAndMarkets.com

Retrieved on:

Monday, July 5, 2021

Hospitals, Pharmaceutical, Health, Medical specialties, Angiology, Cardiovascular system, Vascular surgery, Vascular diseases, Interventional radiology, Endovascular aneurysm repair, Evar, Aneurysm, Neurosurgery, Open aortic surgery, Aortic aneurysm

The "Endovascular Aneurysm Repair (EVAR) Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2021-2026" report has been added to ResearchAndMarkets.com's offering.

Key Points:

The "Endovascular Aneurysm Repair (EVAR) Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2021-2026" report has been added to ResearchAndMarkets.com's offering.
The global endovascular aneurysm repair market exhibited moderate growth during 2015-2020.
Looking forward, the global endovascular aneurysm repair market to grow at a CAGR of around 5% during the forecast period (2021-2026).
Due to the prevalence of aneurysms, along with the growing geriatric population, endovascular treatment is increasingly being adopted by healthcare providers.

Caliber raising funds for heart disease and stroke research

Retrieved on:

Thursday, July 1, 2021

Cardiovascular diseases, American Heart Association, Southwestern Medical District, Cardiovascular disease, Heart, Cardiovascular system, Medicine, Medical specialties

LEWISVILLE, Texas, July 1, 2021 /PRNewswire/ --Caliber, the parent company of Caliber Collision, Caliber Auto Care and Caliber Auto Glass, is launching a new campaign to raise funds to support the American Heart Association 's life-saving heart disease and stroke research.

Key Points:

LEWISVILLE, Texas, July 1, 2021 /PRNewswire/ --Caliber, the parent company of Caliber Collision, Caliber Auto Care and Caliber Auto Glass, is launching a new campaign to raise funds to support the American Heart Association 's life-saving heart disease and stroke research.
"The mission of the American Heart Association deeply resonates with Caliber teammates and families as many have been impacted by heart disease and stroke," said President and CEO of Caliber, Mark Sanders.
"I'm proud of our teammates for living our purpose of Restoring the Rhythm of Your Life daily and raising funds and awareness of this initiative."
According to the American Heart Association, 126.9 million American adults experienced cardiovascular disease between 2015 and 2018.

What is the Silent Killer? It's High Blood Pressure - Interview With Dr. Rajiv Agarwal

Retrieved on:

Wednesday, June 30, 2021

Circulatory system, Cardiovascular system, Anatomy, Aging-associated diseases, Heart diseases, Cardiovascular physiology, Angiology, Hypertension, Cardiology, Coronary artery disease, Peripheral artery disease, Heart failure

HOUSTON, June 30, 2021 /PRNewswire/ -- In this interview, Dr. Rajiv Agarwal , board-certified cardiologist at Modern Heart and Vascular Institute , talked about how understanding blood pressure can help prevent heart attacks and strokes.

Key Points:

HOUSTON, June 30, 2021 /PRNewswire/ -- In this interview, Dr. Rajiv Agarwal , board-certified cardiologist at Modern Heart and Vascular Institute , talked about how understanding blood pressure can help prevent heart attacks and strokes.
Dr. Agarwal talked about the importance of diagnosing symptoms of high blood pressure, causes and treatments to help patients.With a focus on prevention, there are many steps people can take to control hypertension.
To learn more about high blood pressure, please click here .
Modern Heart and Vascular Institute assists with variousheart & vascular symptoms & issues such as chest pain, high cholesterol, congestive heart failure, peripheral arterial disease (PAD), arrhythmia, coronary artery disease, high blood pressure and much more.